back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-08 17:27 Tx date 2024-03-04 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,666
+16,666 vol $1.00 each |
247,485 | |
| Filed 2024-03-08 17:21 Tx date 2024-03-04 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-16,666
-16,666 vol $1.00 each |
20,000 | |
| Filed 2024-03-06 11:38 Tx date 2024-03-06 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,600
+24,000 vol $0.40 each |
254,819 | |
| Filed 2024-01-13 15:48 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$12,482
+11,666 vol $1.07 each |
202,819 | |
| Filed 2024-01-13 15:47 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-12,482.62
-11,666 vol $1.07 each |
71,666 | |
| Filed 2023-11-18 15:28 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$5,200
+5,000 vol $1.04 each |
191,153 | |
| Filed 2023-11-18 15:27 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-5,200
-5,000 vol $1.04 each |
83,332 | |
| Filed 2023-09-15 17:49 Tx date 2023-09-12 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+108,000 vol |
144,000 | |
| Filed 2023-05-03 13:23 Tx date 2023-05-01 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,999
+16,666 vol $0.54 each |
186,153 | |
| Filed 2023-05-03 13:22 Tx date 2023-05-01 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-8,999.64
-16,666 vol $0.54 each |
88,332 | |
| Filed 2023-03-06 12:18 Tx date 2023-03-03 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,500
+16,667 vol $0.51 each |
169,487 | |
| Filed 2023-03-06 12:17 Tx date 2023-03-03 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-8,500.17
-16,667 vol $0.51 each |
104,998 | |
| Filed 2023-01-14 15:44 Tx date 2023-01-11 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,883
+11,667 vol $0.59 each |
152,820 | |
| Filed 2023-01-14 15:44 Tx date 2023-01-11 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-6,883.53
-11,667 vol $0.59 each |
121,665 | |
| Filed 2022-11-19 12:05 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,400
+5,000 vol $0.48 each |
127,623 | |
| Filed 2022-11-19 12:04 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-2,400
-5,000 vol $0.48 each |
133,332 | |
| Filed 2022-11-19 12:00 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+36,000 vol |
36,000 | |
| Filed 2022-11-19 11:58 Tx date 2020-05-01 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-11-16 20:05 Tx date 2022-11-16 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,897
+13,530 vol $0.362 each |
136,153 | |
| Filed 2022-08-19 14:12 Tx date 2022-08-16 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,716
+3,300 vol $0.52 each |
122,623 |